文献速递肝病消化道肿瘤与早癌

晚期肝病患者不确定性肝结节的自然史:一项多中心回顾性队列研究

Natural History of Indeterminate Liver Nodules in Patients With Advanced Liver Disease: A Multicenter Retrospective Cohort Study.
PubMed 文献 · Am J Gastroenterol · 2024-04-30

该多中心回顾性队列研究纳入2018年1月至2019年12月期间新检出≥1个≥1 cm的LI-RADS 3(LR-3)病灶或任意大小的LI-RADS 4(LR-4)病灶的307例患者,评估不确定性肝结节(ILN)的自然史。LR-3和LR-4患者肝细胞癌(HCC)发病率分别为每1000人年110(95%CI 70-150)和420(95%CI 310-560)。LR-4病灶患者HCC风险较LR-3病灶患者高4倍。

要点

  • LR-3患者HCC发病率为每1000人年110(95%CI 70-150),LR-4为每1000人年420(95%CI 310-560)。
  • LR-3患者发生HCC与年龄较大、血小板减少(血小板计数≤150×10^9/L)及血清甲胎蛋白升高相关。
  • LR-4患者发生HCC与最大病灶直径>1 cm相关。

核心结论

  • ILN具有较高但可变的HCC风险,LR-4病灶患者风险较LR-3病灶患者高4倍,凸显了准确风险分层工具和密切随访的必要性。

研究设计与样本

  • 多中心回顾性队列研究,纳入2018年1月至2019年12月期间新检出≥1个≥1 cm的LI-RADS 3(LR-3)病灶或任意大小的LI-RADS 4(LR-4)病灶(依据LI-RADS v2018)的患者。
  • 共307例ILN患者,其中208例有LR-3病灶,83例有LR-4病灶,16例同时有LR-3和LR-4病灶。
  • 各中心按机构标准治疗进行重复影像学随访,采用多变量Fine-Gray模型评估潜在危险因素与患者层面至HCC诊断时间的关联,以死亡和肝移植为竞争风险。

主要发现

  • LR-3病灶患者HCC发病率为每1000人年110(95%CI 70-150),LR-4病灶患者为每1000人年420(95%CI 310-560)。
  • 多变量分析中,LR-3病灶患者发生HCC与年龄较大、血小板减少(血小板计数≤150×10^9/L)及血清甲胎蛋白升高相关。
  • LR-4病灶患者发生HCC与最大病灶直径>1 cm相关。
  • 多数患者接受随访计算机断层扫描或磁共振成像,但13.7%无随访影像学检查,另14.3%仅接受随访超声检查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Indeterminate liver nodules (ILNs) are frequently encountered on diagnostic imaging after positive hepatocellular carcinoma (HCC) surveillance results, but their natural history remains unclear. METHODS: We conducted a multicenter retrospective cohort study among patients with ≥1 newly detected LI-RADS 3 (LR-3) lesion ≥1 cm or LI-RADS 4 (LR-4) lesion of any size (per LI-RADS v2018) between January 2018 and December 2019. Patients were followed with repeat imaging at each site per institutional standard of care. Multivariable Fine-Gray models were used to evaluate associations between potential risk factors and patient-level time-to-HCC diagnosis, with death and liver transplantation as competing risks. RESULTS: Of 307 patients with ILNs, 208 had LR-3 lesions, 83 had LR-4 lesions, and 16 had both LR-3 and LR-4 lesions. HCC incidence rates for patients with LR-3 and LR-4 lesions were 110 (95% CI 70-150) and 420 (95% CI 310-560) per 1,000 person-year, respectively. In multivariable analysis, incident HCC among patients with LR-3 lesions was associated with older age, thrombocytopenia (platelet count ≤150 ×10 9 /L), and elevated serum alpha-fetoprotein levels. Among those with LR-4 lesions, incident HCC was associated with a maximum lesion diameter >1 cm. Although most patients had follow-up computed tomography or magnetic resonance imaging, 13.7% had no follow-up imaging and another 14.3% had follow-up ultrasound only. DISCUSSION: ILNs have a high but variable risk of HCC, with 4-fold higher risk in patients with LR-4 lesions than those with LR-3 lesions, highlighting a need for accurate risk stratification tools and close follow-up in this population.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Singal AG, Parikh ND, Shetty K, et al. Natural History of Indeterminate Liver Nodules in Patients With Advanced Liver Disease: A Multicenter Retrospective Cohort Study. Am J Gastroenterol. 2024. PMID: 38686922. doi:10.14309/ajg.0000000000002827

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。